Under the fresh terms of their strategic alliance, Serum Life Sciences will make an additional equity investment of $150 million through the conversion of the $150 million loan provided to Biocon Pharma, a wholly-owned subsidiary of Biocon, into equity in BBL.
Sebi proposes tighter curbs on promotional claims by online bond platforms
Sebi is tightening the reins on advertising practices for online bond platforms, aiming to protect investors from hasty decisions. New rules mandate that promotional content